InsiderClue
Insiders · Profile

Krause Kevin Michael

Chief Strategy Officer at AN2 Therapeutics. Filing since 2 Jan 2024. CIK 0001916925

Company
Date
Role
Action
Shares
Amount
Of holding
ANTX AN2 Therapeutics, Inc.
9 Jan 2024
Chief Strategy Officer
Sold on a plan
7,417
$149.37K
79.5%
ANTX AN2 Therapeutics, Inc.
2 Jan 2024
Chief Strategy Officer
Sold on a plan
2,583
$51.97K
57.4%
2 decisions on file.